Your browser doesn't support javascript.
loading
Transferrin iron starvation therapy for lethal bacterial and fungal infections.
Lin, Lin; Pantapalangkoor, Paul; Tan, Brandon; Bruhn, Kevin W; Ho, Tiffany; Nielsen, Travis; Skaar, Eric P; Zhang, Yaofang; Bai, Ruipeng; Wang, Amy; Doherty, Terence M; Spellberg, Brad.
Afiliação
  • Lin L; The Los Angeles Biomedical Research Institute, Torrance, California The Division of General Internal Medicine, Harbor-University of California at Los Angeles (UCLA) Medical Center, Torrance The David Geffen School of Medicine at UCLA, Los Angeles.
  • Pantapalangkoor P; The Los Angeles Biomedical Research Institute, Torrance, California.
  • Tan B; The Los Angeles Biomedical Research Institute, Torrance, California.
  • Bruhn KW; The Los Angeles Biomedical Research Institute, Torrance, California The Division of General Internal Medicine, Harbor-University of California at Los Angeles (UCLA) Medical Center, Torrance The David Geffen School of Medicine at UCLA, Los Angeles.
  • Ho T; The Los Angeles Biomedical Research Institute, Torrance, California.
  • Nielsen T; The Los Angeles Biomedical Research Institute, Torrance, California.
  • Skaar EP; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Zhang Y; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Bai R; The Los Angeles Biomedical Research Institute, Torrance, California.
  • Wang A; The Los Angeles Biomedical Research Institute, Torrance, California.
  • Doherty TM; The Los Angeles Biomedical Research Institute, Torrance, California.
  • Spellberg B; The Los Angeles Biomedical Research Institute, Torrance, California The Division of General Internal Medicine, Harbor-University of California at Los Angeles (UCLA) Medical Center, Torrance The David Geffen School of Medicine at UCLA, Los Angeles.
J Infect Dis ; 210(2): 254-64, 2014 Jul 15.
Article em En | MEDLINE | ID: mdl-24446527
New strategies to treat antibiotic-resistant infections are urgently needed. We serendipitously discovered that stem cell conditioned media possessed broad antimicrobial properties. Biochemical, functional, and genetic assays confirmed that the antimicrobial effect was mediated by supra-physiological concentrations of transferrin. Human transferrin inhibited growth of gram-positive (Staphylococcus aureus), gram-negative (Acinetobacter baumannii), and fungal (Candida albicans) pathogens by sequestering iron and disrupting membrane potential. Serial passage in subtherapeutic transferrin concentrations resulted in no emergence of resistance. Infected mice treated with intravenous human transferrin had improved survival and reduced microbial burden. Finally, adjunctive transferrin reduced the emergence of rifampin-resistant mutants of S. aureus in infected mice treated with rifampin. Transferrin is a promising, novel antimicrobial agent that merits clinical investigation. These results provide proof of principle that bacterial infections can be treated in vivo by attacking host targets (ie, trace metal availability) rather than microbial targets.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Infecções por Acinetobacter / Candidíase / Transferrina / Ferro Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Infecções por Acinetobacter / Candidíase / Transferrina / Ferro Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article